Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

Popular Articles

Volatility set to rise
- Traders expect resistance above 5,100 - Expiry effect in overbought market - Traders expect index to move below 5,000 in near future - Market may open on a steady note - Far from money spreads could pay - Nifty likely to see more corrections in near term

Caraco agrees to undertake action to get USFDA ban lifted
Sun Pharma"s US-based subsidiary Caraco Pharmaceuticals has agreed to undertake a series of measures as per requirements of the US health regulator Food and Drug Administration (FDA) to get a ban on its manufacturing units lifted.

News of the day

A V Rajwade: For that perfect hedge
A V Rajwade / New Delhi November 7, 2009, 0:40 IST
Online Business

Zydus Cadila files anti-diabetic drug application with DCGI

Healthcare services provider Zydus Cadila has filed an application before the Drugs Controller General of India (DCGI) for its anti-diabetic drug. The company has filed an investigational new drug (IND) application before the DCGI for its ZYD1 drug, used in the treatment of diabetes, Cadila Healthcare, the flagship company of Zydus Cadila group, said in a filing to the Bombay Stock Exchange. The global anti-diabetic market is estimated at Rs 24 billion dollars in 2008.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009